RAMM Pharma Corp. Announces Non-Brokered Private Placement and Intention to Commence Normal Course Issuer Bid TORONTO, Sept. 05, 2023 (GLOBE NEWSWIRE) -- RAMM Pharma Corp. (including its wholly owned subsidiaries, the “Company” or "RAMM") (CSE: RAMM), announces that it intends to complete a non-brokered...

RAMM Pharma Corp. Acquires Leading European Hemp Manufacturer HemPoland TORONTO, Sept. 06, 2022 (GLOBE NEWSWIRE) -- RAMM Pharma Corp. (including its wholly owned subsidiaries, the “Company” or "RAMM") (CSE: RAMM), is pleased to announce that today it has acquired all of...

Canapar Acquired by RAMM Pharma RAGUSA, Italy, May 25, 2021 (GLOBE NEWSWIRE) -- Canapar Corp. (“Canapar”) today announced a definitive agreement with RAMM Pharma Corp. (including its wholly owned subsidiaries, “RAMM”) for RAMM to...

Canapar Welcomes RAMM Pharma as Strategic Shareholder; Closes $6,427,000 Financing RAGUSA, Italy, Jan. 20, 2021 (GLOBE NEWSWIRE) -- Canapar Corp. (“Canapar”) and RAMM Pharma Corp. (including its wholly owned subsidiaries, "RAMM") (CSE: RAMM) are pleased to announce they have...